OR3O Dual Mobility
Device
Smith+Nephew, Inc.
Total Payments
$3.1M
Transactions
1,902
Doctors
506
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $893,430 | 253 | 113 |
| 2023 | $1.4M | 1,234 | 281 |
| 2022 | $808,334 | 415 | 212 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.3M | 173 | 40.8% |
| Consulting Fee | $876,104 | 176 | 27.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $314,262 | 41 | 10.0% |
| Travel and Lodging | $307,479 | 559 | 9.8% |
| Royalty or License | $251,461 | 8 | 8.0% |
| Food and Beverage | $105,606 | 942 | 3.4% |
| Space rental or facility fees (teaching hospital only) | $4,000 | 1 | 0.1% |
| Debt forgiveness | $3,757 | 1 | 0.1% |
| Education | $479.00 | 1 | 0.0% |
Payments by Type
General
$1.9M
1,729 transactions
Research
$1.3M
173 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Prospective Multi-Center study to evaluate the safety and effectiveness of the OR30 Dual Mobility system in primary and revision total hip arthroplasty (THA) procedures | Smith+Nephew, Inc. | $934,813 | 0 |
| A prospective Study on OR30 Dual Mobility Total Hip Arthroplasty System to Evaluate Metal Ion Levels | Smith+Nephew, Inc. | $153,825 | 0 |
| Data Capture relating to the OR30 Dual Mobility | Smith+Nephew, Inc. | $131,378 | 0 |
| Early clinical outcomes for the OR3O dual mobility hip system in Primary and Revision Total Hip Arthroplasty - A data capture study | Smith+Nephew, Inc. | $32,850 | 0 |
| Plasma Metal Ion Levels with Dual Mobility Bearing Articulations in Total Hip Arthroplasty: Comparison of Various Implant Types and Duration | Smith+Nephew, Inc. | $30,000 | 0 |
Top Doctors Receiving Payments for OR3O Dual Mobility
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | New York, NY | $1.3M | 176 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Orlando, FL | $187,033 | 41 |
| , M.D | Orthopaedic Surgery | New York, NY | $183,662 | 34 |
| , M.D | Orthopaedic Surgery | New York, NY | $155,042 | 5 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Lexington, KY | $143,858 | 35 |
| , M.D., PH.D | Adult Reconstructive Orthopaedic Surgery | Durham, NC | $126,281 | 34 |
| , M.D., M.SC | General Acute Care Hospital | White Plains, NY | $96,078 | 26 |
| , MD | Orthopaedic Surgery | San Francisco, CA | $46,192 | 25 |
| , M.D., PH. D | Adult Reconstructive Orthopaedic Surgery | Pittsburgh, PA | $42,504 | 27 |
| , MD | Orthopaedic Surgery | Falmouth, ME | $39,879 | 13 |
| , M.D | Orthopaedic Surgery | Dallas, TX | $35,269 | 29 |
| , M.D | Orthopaedic Surgery | New York, NY | $35,041 | 23 |
| , M.D | Orthopaedic Surgery | Durham, NC | $29,487 | 10 |
| , M.D | Orthopaedic Surgery | Atlanta, GA | $29,480 | 19 |
| , MD | Orthopaedic Surgery | Philadelphia, PA | $25,785 | 13 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Stanford, CA | $24,683 | 18 |
| , M.D | Orthopaedic Surgery | Morton Grove, IL | $24,576 | 13 |
| , M.D | Surgical Oncology | Santa Monica, CA | $23,053 | 15 |
| , MD | Orthopaedic Surgery | Buffalo, NY | $22,808 | 12 |
| , MD | Orthopaedic Surgery | Santa Monica, CA | $18,961 | 4 |
| , MD | Orthopaedic Surgery | Gainesville, FL | $18,928 | 11 |
| , M.D | Orthopaedic Surgery | Vero Beach, FL | $18,243 | 5 |
| , M.D | Orthopaedic Surgery | New York, NY | $18,180 | 7 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Chevy Chase, MD | $17,312 | 8 |
| , MD | Orthopaedic Surgery | Buffalo, NY | $17,132 | 4 |
Ad
Manufacturing Companies
- Smith+Nephew, Inc. $3.1M
Product Information
- Type Device
- Total Payments $3.1M
- Total Doctors 506
- Transactions 1,902
About OR3O Dual Mobility
OR3O Dual Mobility is a device associated with $3.1M in payments to 506 healthcare providers, recorded across 1,902 transactions in the CMS Open Payments database. The primary manufacturer is Smith+Nephew, Inc..
Payment data is available from 2022 to 2024. In 2024, $893,430 was paid across 253 transactions to 113 doctors.
The most common payment nature for OR3O Dual Mobility is "Unspecified" ($1.3M, 40.8% of total).
OR3O Dual Mobility is associated with 5 research studies, including "Prospective Multi-Center study to evaluate the safety and effectiveness of the OR30 Dual Mobility system in primary and revision total hip arthroplasty (THA) procedures" ($934,813).